Proton Therapy Market Research Report 2024
Proton Therapy Market Global Industry Analysis and Forecast (2024-2032) By Setup Type (Single-Room Systems, Multi-Room Systems), Technology (Cyclotron-Based, Synchrotron-Based), Application (Pediatric Cancer, Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, And Others (Brain Cancer, Gastrointestinal Cancer, Ocular tumors)), Delivery Method (Fixed Beam, Scanning Beam), End-user (Hospitals, Proton Therapy Centres), And Region
Proton Therapy Market Synopsis
Proton Therapy Market Size Was Valued at USD 578.16 Million in 2023 and is Projected to Reach USD 1910.04 Million by 2032, Growing at a CAGR of 14.20% From 2024-2032.
Proton therapy is a specific form of radiation therapy that utilizes high-energy protons to pinpoint cancerous areas while causing minimal harm to nearby healthy tissue. This treatment effectively targets different types of cancer.Proton therapy provides precise cancer treatment, minimizing harm to surrounding healthy tissues and decreasing the chance of developing secondary cancer.
It enhances the quality of life by saving healthy organs, leading to decreased side effects. Proton therapy is successful for complicated situations and is not intrusive, removing the necessity for surgery.Patients can get back to their normal routines faster due to the shorter treatment times and fewer sessions required. Due to technological advancements and the increased availability of proton therapy centers, more patients now have the opportunity to undergo this treatment.
Top Active Players Involved Are:
“Advanced Oncotherapy plc (United Kingdom), Hitachi, Ltd (Japan), IBA Worldwide (Belgium), Mevion Medical Systems (United States), Mitsubishi Corporation (Japan), Optivus Proton Therapy (United States), ProTom International (United States), Provision Healthcare (United States), Sumitomo Heavy Industries, Ltd (Japan), Varian Medical Systems, Inc (United States), ProNova Solutions LLC (United States), Sun Nuclear Corporation (United States), Koninklijke Philips N.V (Netherlands), Elekta AB (Sweden), GE Healthcare (United States), Best Cyclotron Systems (Canada), Ray Search Laboratories (Sweden), Permedics (United Kingdom), China National Nuclear Corporation (CNNC) (China), Samsung Medical Center (South Korea), Shanghai ApolloProton Cancer Centre (China), Taiwan Main Orthopaedics Biotechnology (Taiwan), Sino-American Shanghai Squibb Lying-in Hospital (China), University of Pennsylvania Roberts Proton Therapy Center (United States), and Other Active Players.”
Proton Therapy Market Trend Analysis
Rising Occurrence of Cancer
- The number of cancer cases is on the rise globally because of reasons such as getting older, changes in lifestyle, exposure to cancer-causing substances, and genetics. This increase underscores the importance of having more advanced treatment choices, with proton therapy particularly noted for its accurate targeting of tumors and minimized harm to surrounding healthy tissues.
- Proton therapy is advantageous for intricate cases near important organs, providing better results and decreased side effects when compared to standard radiation therapy.
- In the field of paediatric oncology, it is essential for proton therapy to reduce radiation exposure to growing organs in order to prevent long-term side effects. The increase in proton therapy facilities worldwide demonstrates the increasing need for this advanced treatment, granting a larger number of patients the opportunity to benefit from it.
- Ongoing technological developments in proton therapy, including enhanced delivery methods and imaging tools, continue to improve its effectiveness and efficiency, drawing interest from healthcare providers and promoting its use in treating cancer.
Restraint High Treatment Costs
- Proton therapy facilities need significant funding for specialized infrastructure and equipment, as well as trained staff for treatment administration. The cost of establishing a center and difficulties with insurance reimbursement can hinder patient's access to proton therapy.
- Sophisticated software for treatment planning and advanced imaging methods contribute to the total cost of treatment. Restricted insurance coverage may not completely offset the increased cost of proton therapy, leading to financial obstacles for patients.
- The scarcity of proton therapy centers may lead to added expenses for patients required to journey far for treatment. Proton therapy needs to prove its cost-effectiveness in comparison to other treatments in order to justify its expensive cost.
- In general, the costly nature of proton therapy presents difficulties for both healthcare providers and patients in terms of accessibility and affordability.
Source: Company Database
- Lung cancer is the deadliest cancer worldwide, accounting for 1.82 million deaths in 2023. The second most deadly form of cancer is colorectum cancer, followed by liver cancer. However, lung cancer is only the sixth leading cause of death worldwide, with heart disease and stroke accounting for the highest share of deaths.
Opportunity Increased Research and Development
- Efforts in proton therapy research and development aim to improve treatments, minimize side effects, enhance imaging and targeting, tailor treatment plans, enhance particle beam technology, carry out comparative studies, and investigate advantages in pediatric oncology and survivorship care.
- The goal of these initiatives is to increase the accuracy and efficiency of proton therapy, broaden its range of uses, enhance patient well-being, provide accurate radiation administration, and minimize unnecessary radiation exposure.
- Researchers are seeking to prove the clinical benefits, efficacy, and cost-effectiveness of proton therapy for certain cancer types and patient groups through clinical data and comparative research.
- Innovations in technology and advancements in proton therapy could transform cancer treatment through the provision of more precise, individualized, and effective therapies that result in fewer side effects and better results.
Proton Therapy Market Segment Analysis:
Proton Therapy market is segmented on the basis of Setup Type, Technology, Application, Delivery Method, and End-user.
By Setup Type, Multi-Room Systems Segment Is Expected to Dominate the Market During the Forecast Period
There are two segments by setup type such as single-room systems, and multi-room systems. Among these, the multi-room systems segment is expected to dominate the market during the forecast period.
- Multi-room proton therapy systems provide greater treatment capacity and scalability than single-room systems, enabling smooth patient flow and higher revenue generation.
- They offer a variety of options like IMPT and PBS for different types of tumors, giving flexibility in treatment planning and execution. Having several treatment rooms, these systems decrease treatment waiting periods, improve patient contentment, and maximize resource efficiency.
- Enhanced operational efficiency is achieved with specialized treatment areas and monitoring stations, resulting in higher patient flow and revenue opportunities. Multi-room systems enhance patient accessibility to proton therapy, particularly in areas with high demand or few centers available.
- Ongoing technological advancements aim to enhance treatment results and promote the use of multi-room configurations. Optimizing equipment design and reducing maintenance costs make multi-room systems more financially feasible for healthcare providers, achieving cost-effectiveness.
By Delivery Type, Scanning Beam Segment Held the Largest Share In 2023
There are two segments by delivery type such as fixed beam and scanning beam. Among these, the scanning beam segment held the largest share in 2023.
- Scanning beam delivery provides accurate targeting for tumors, outperforming fixed beam delivery in precision. The radiation dose is controlled by the dynamic system to minimize harm to surrounding healthy tissues near tumors.
- It enables specialized radiation delivery for various cancer types through features such as pencil beam scanning and intensity-modulated proton therapy. This lowers the toxicity of normal tissue by protecting healthy tissues, making it well-suited for tumors close to vital organs.
- The treatment planning system adjusts based on tumor size or position changes to ensure precise targeting. By reducing treatment times, patient comfort and convenience are improved during therapy.
- Advances in imaging technology and motion management enhance the accuracy of treatments. Clinical studies provide proof of its effectiveness in difficult situations such as pediatric tumors and skull-base cancers, influencing the decisions of cancer specialists.
Proton Therapy Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast Period
- North America has top-notch healthcare infrastructure, including cutting-edge proton therapy centers and specialized cancer treatment facilities, positioning it as a leader in the healthcare market.
- The area has reimbursement policies that support the accessibility of proton therapy for different cancer types, boosted by research collaborations that promote advancements in treatment methods and technology.
- The increasing prevalence of cancer in North America drives the need for proton therapy, which is recognized for its accuracy and fewer side effects in comparison to conventional radiation therapy.
- Improvements in technology for equipment and software boost the effectiveness and productivity of proton therapy treatments, drawing in patients and healthcare providers. The FDA leads the strict regulatory framework in
- North America to guarantee safety and quality standards in proton therapy systems. The adoption of personalized medicine in the region matches the precision technique of proton therapy, leading to its increased use and strengthening North America's market leadership in the industry.
Proton Therapy Market Active Players
- Advanced Oncotherapy plc (United Kingdom)
- Hitachi, Ltd (Japan)
- IBA Worldwide (Belgium)
- Mevion Medical Systems (United States)
- Mitsubishi Corporation (Japan)
- Optivus Proton Therapy (United States)
- ProTom International (United States)
- Provision Healthcare (United States)
- Sumitomo Heavy Industries, Ltd (Japan)
- Varian Medical Systems, Inc (United States)
- ProNova Solutions LLC (United States)
- Sun Nuclear Corporation (United States)
- Koninklijke Philips N.V (Netherlands)
- Elekta AB (Sweden)
- GE Healthcare (United States)
- Best Cyclotron Systems (Canada)
- Ray Search Laboratories (Sweden)
- Permedics (United Kingdom)
- China National Nuclear Corporation (CNNC) (China)
- Samsung Medical Center (South Korea)
- Shanghai ApolloProton Cancer Centre (China)
- Taiwan Main Orthopaedics Biotechnology (Taiwan)
- Sino-American Shanghai Squibb Lying-in Hospital (China)
- University of Pennsylvania Roberts Proton Therapy Center (United States)
- National Cancer Hospital Vietnam (Vietnam), and Other Active Players.
Key Industry Developments in the Proton Therapy Market:
- In January 2024, OncoRay's research group launched the world's first research prototype for whole-body MRI-guided proton therapy. The prototype allows real-time MRI tracking of moving tumors during treatment. Proton therapy offers precise treatment with reduced doses to healthy tissue.
- In February 2024, The Apollo Proton Cancer Centre launched the 'Dr APJ Abdul Kalam Therapy Bay' with a high-tech treatment technique called image-guided intensity modulated proton therapy (IG-IMPT). It aims to provide comprehensive and advanced cancer care in India.
|
Proton Therapy Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 578.16 Mn. |
|
Forecast Period 2024-32 CAGR: |
14.20 % |
Market Size in 2032: |
USD 1910.04 Mn. |
|
Segments Covered: |
By Setup Type |
|
|
|
By Technology |
|
||
|
By Application |
|
||
|
By Delivery Method |
|
||
|
By End-user |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Proton Therapy Market by By Setup Type
4.1 Proton Therapy Market Snapshot and Growth Engine
4.2 Proton Therapy Market Overview
4.3 Single-Room Systems
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in
Frequently Asked Questions
What would be the forecast period in the Proton Therapy Market research report?
The forecast period in the Proton Therapy Market research report is 2024-2032.
Who are the key players in the Proton Therapy Market?
Advanced Oncotherapy plc (United Kingdom), Hitachi, Ltd (Japan), IBA Worldwide (Belgium), Mevion Medical Systems (United States), Mitsubishi Corporation (Japan), Optivus Proton Therapy (United States), ProTom International (United States), Provision Healthcare (United States), Sumitomo Heavy Industries, Ltd (Japan), Varian Medical Systems, Inc (United States), ProNova Solutions LLC (United States), Sun Nuclear Corporation (United States), Koninklijke Philips N.V (Netherlands), Elekta AB (Sweden), GE Healthcare (United States), Best Cyclotron Systems (Canada), Ray Search Laboratories (Sweden), Permedics (United Kingdom), China National Nuclear Corporation (CNNC) (China), Samsung Medical Center (South Korea), Shanghai ApolloProton Cancer Centre (China), Taiwan Main Orthopaedics Biotechnology (Taiwan), Sino-American Shanghai Squibb Lying-in Hospital (China), University of Pennsylvania Roberts Proton Therapy Center (United States), National Cancer Hospital Vietnam (Vietnam), and Other Active Players.
What are the segments of the Proton Therapy Market?
The Proton Therapy Market is segmented into Setup Type, Technology, Application, Delivery Method, End-user, and region. By Setup Type, the market is categorized into Single-Room Systemsand multi-room Systems. By Technology, the market is categorized into Cyclotron-Based, Synchrotron-Based. By Application, the market is categorized into Pediatric Cancer, Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, And Others (Brain Cancer, Gastrointestinal Cancer, and Ocular tumours). By Delivery Method, the market is categorized into Fixed Beam, and Scanning Beam. By End-user, The Market Is Categorized Into Hospitals, Proton Therapy Centres. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
What is the Proton Therapy Market?
Proton therapy is a specific form of radiation therapy that utilizes high-energy protons to pinpoint cancerous areas while causing minimal harm to nearby healthy tissue. This treatment effectively targets different types of cancer.
How big is the Proton Therapy Market?
Proton Therapy Market Size Was Valued at USD 578.16 Million in 2023 and is Projected to Reach USD 1910.04 Million by 2032, Growing at a CAGR of 14.20% From 2024-2032.
